Globus Medical share price today
(NASDAQ: GMED)

Name: Globus Medical Share Price Today (NASDAQ: GMED) - Globus Medical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Globus Medical share price is $92.42 & ₹7,993.41 as on 24 Jan 2025, 2.30 'hrs' IST

$92.42

▲

-0.9

(-0.96%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Globus Medical share price in Dollar and Rupees. Guide to invest in Globus Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Globus Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Globus Medical share price movements

Today's Low: $91.59
Today's High: $93.25
$92.42
0.9%
Downside
Day's Volatility :1.78%
Upside
0.89%
52 Weeks Low: $49.33
52 Weeks High: $93.67
$92.42
46.62%
Downside
52 Weeks Volatility :47.34%
Upside
1.33%

Globus Medical Returns

Period	Globus Medical, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	27.54%	-5.5%	0.0%
6 Months	29.81%	-4.3%	0.0%
1 Year	73.65%	1.6%	0.0%
3 Years	41.67%	9.8%	-11.0%

Globus Medical Key Statistics

in dollars & INR

Previous Close	$93.32
Open	$93.24
Today's High	$93.25
Today's Low	$91.59
Market Capitalization	$12.6B
Today's Volume	$1.0M
52 Week High	$93.67
52 Week Low	$49.33
Revenue TTM	$2.5B
EBITDA	$652.0M
Earnings Per Share (EPS)	$0.62
PE Ratio	149.05
Profit Margin	3.69%
Quarterly Earnings Growth YOY	42.23%
Return On Equity TTM	2.22%

How to invest in Globus Medical Stock (GMED) from India?

It is very easy for Indian residents to invest directly in Globus Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Globus Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Globus Medical or GMED on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Globus Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Globus Medical shares which would translate to 0.009 fractional shares of Globus Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Globus Medical, in just a few clicks!

Returns in Globus Medical for Indian investors in Rupees

Investment Value

₹1,00,000

Globus Medical investment value today

Current value as on today

₹1,76,031

Returns

₹76,031

(+76.03%)

Returns from Globus Medical Stock

₹71,976 (+71.98%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Globus Medical

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Globus Medical on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 5% more investors are searching Globus Medical in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Globus Medical

Name	Shares Held	Change in Shares	% of Assets
DSP Healthcare Fund Direct Growth	268800	185090.30	5.70%

Global Institutional Holdings in Globus Medical

Vanguard Group Inc
7.80%
BlackRock Inc
7.54%
HHG PLC
5.14%
State Street Corp
2.62%
JPMorgan Chase & Co
1.91%
Wellington Management Company LLP
1.89%

Analyst Recommendation on Globus Medical

Buy

54%Buy

40%Hold

4%Sell

Based on 22 Wall street analysts offering stock ratings for Globus Medical(by analysts ranked 0 to 5 stars)

Based on 22 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Globus Medical

What analysts predicted

Upside of 5.87%

Target:

$97.85

Current:

$92.42

Insights on Globus Medical

Price Movement
In the last 1 month, GMED stock has moved up by 12.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 629.69M → 625.70M (in $), with an average decrease of 0.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -7.11M → 51.83M (in $), with an average increase of 80.6% per quarter
GMED vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 133.4% return, outperforming this stock by 96.0%

Globus Medical Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$713.0M	↑ 12.11%
Net Income	$156.5M	↑ 45.76%
Net Profit Margin	21.95%	↑ 5.07%

	FY19	Y/Y Change
Revenue	$785.4M	↑ 10.15%
Net Income	$155.2M	↓ 0.81%
Net Profit Margin	19.76%	↓ 2.19%

	FY20	Y/Y Change
Revenue	$789.0M	↑ 0.47%
Net Income	$102.3M	↓ 34.1%
Net Profit Margin	12.96%	↓ 6.8%

	FY21	Y/Y Change
Revenue	$958.1M	↑ 21.43%
Net Income	$149.2M	↑ 45.86%
Net Profit Margin	15.57%	↑ 2.61%

	FY22	Y/Y Change
Revenue	$1.0B	↑ 6.76%
Net Income	$190.2M	↑ 27.47%
Net Profit Margin	18.59%	↑ 3.02%

	FY23	Y/Y Change
Revenue	$1.6B	↑ 53.34%
Net Income	$122.9M	↓ 35.39%
Net Profit Margin	7.83%	↓ 10.76%

	Q2 FY23	Q/Q Change
Revenue	$291.6M	↑ 5.39%
Net Income	$57.7M	↑ 17.47%
Net Profit Margin	19.79%	↑ 2.03%

	Q3 FY23	Q/Q Change
Revenue	$383.6M	↑ 31.56%
Net Income	$998.0K	↓ 98.27%
Net Profit Margin	0.26%	↓ 19.53%

	Q4 FY23	Q/Q Change
Revenue	$616.5M	↑ 60.71%
Net Income	$15.0M	↑ 1406.41%
Net Profit Margin	2.44%	↑ 2.18%

	Q1 FY24	Q/Q Change
Revenue	$606.7M	↓ 1.6%
Net Income	$-7.1M	↓ 147.34%
Net Profit Margin	-1.17%	↓ 3.61%

	Q2 FY24	Q/Q Change
Revenue	$629.7M	↑ 3.8%
Net Income	$31.8M	↓ 546.26%
Net Profit Margin	5.04%	↑ 6.21%

	Q3 FY24	Q/Q Change
Revenue	$625.7M	↓ 0.63%
Net Income	$51.8M	↑ 63.21%
Net Profit Margin	8.28%	↑ 3.24%

	FY18	Y/Y Change
Profit	$553.6M	↑ 14.01%

	FY19	Y/Y Change
Profit	$605.4M	↑ 9.36%

	FY20	Y/Y Change
Profit	$571.6M	↓ 5.59%

	FY21	Y/Y Change
Profit	$718.9M	↑ 25.77%

	FY22	Y/Y Change
Profit	$759.1M	↑ 5.6%

	FY23	Y/Y Change
Profit	$1.0B	↑ 34.41%

	Q2 FY23	Q/Q Change
Profit	$215.1M	↑ 4.51%

	Q3 FY23	Q/Q Change
Profit	$248.2M	↑ 15.39%

	Q4 FY23	Q/Q Change
Profit	$351.0M	↑ 41.41%

	Q1 FY24	Q/Q Change
Profit	$335.5M	↓ 4.43%

	Q2 FY24	Q/Q Change
Profit	$339.9M	↑ 1.32%

	Q3 FY24	Q/Q Change
Profit	$325.1M	↓ 4.36%

	FY18	Y/Y Change
Operating Cash Flow	$181.6M	↑ 13.86%
Investing Cash Flow	$-193.0M	↑ 73.47%
Financing Cash Flow	$32.6M	↑ 1903.08%

	FY19	Y/Y Change
Operating Cash Flow	$172.0M	↓ 5.32%
Investing Cash Flow	$-140.3M	↓ 27.33%
Financing Cash Flow	$24.4M	↓ 24.96%

	FY20	Y/Y Change
Operating Cash Flow	$198.8M	↑ 15.59%
Investing Cash Flow	$-117.3M	↓ 16.37%
Financing Cash Flow	$-38.7M	↓ 258.2%

	FY21	Y/Y Change
Operating Cash Flow	$276.3M	↑ 38.98%
Investing Cash Flow	$-375.9M	↑ 220.43%
Financing Cash Flow	$54.1M	↓ 240.05%

	FY22	Y/Y Change
Operating Cash Flow	$178.5M	↓ 35.4%
Investing Cash Flow	$-110.4M	↓ 70.64%
Financing Cash Flow	$-110.0M	↓ 303.08%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$35.0M	↓ 34.3%
Investing Cash Flow	$52.2M	↑ 375.09%
Financing Cash Flow	$1.1M	↓ 63.13%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$50.5M	↑ 44.12%
Investing Cash Flow	$-80.9M	↓ 254.84%
Financing Cash Flow	$1.4M	↑ 31.46%

Globus Medical Technicals Summary

Sell

Neutral

Buy

Globus Medical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Globus Medical Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Globus Medical, Inc.	10.54%	29.81%	73.65%	41.67%	76.68%
Medtronic Plc	7.73%	11.61%	2.39%	-15.68%	-26.33%
Edwards Lifesciences Corp.	-8.41%	10.69%	-6.13%	-36.94%	-9.52%
Boston Scientific Corp.	10.15%	33.89%	64.9%	135.97%	135.19%
Stryker Corporation	5.32%	17.73%	25.19%	56.65%	81.96%
Abbott Laboratories	2.63%	11.92%	4.74%	-4.45%	31.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Globus Medical, Inc.	149.05	149.05	2.4	2.99	0.02	0.05	NA	29.94
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Globus Medical, Inc.	Buy	$12.6B	76.68%	149.05	3.69%
Medtronic Plc	Buy	$113.3B	-26.33%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.52%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	135.19%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	81.96%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Organization	Globus Medical
Employees	5000
CEO	Mr. David C. Paul
Industry	Health Technology

Management People of Globus Medical

Name	Title
Mr. David C. Paul	Co-Founder & Executive Chairman
Mr. Daniel T. Scavilla	President, CEO & Director
Mr. Keith W. Pfeil	CFO & COO
Ms. Kelly G. Huller Esq.	Executive Vice President & General Counsel
Mr. Brian J. Kearns	Senior Vice President of Business Development & Investor Relations

Important FAQs about investing in Globus Medical (GMED) from India :

What is Globus Medical share price today?

Globus Medical share price today stands at $92.42, Open: $93.24 ; Previous Close: $93.32 ; High: $93.25 ; Low: $91.59 ; 52 Week High: $93.67 ; 52 Week Low: $49.33. The stock opens at $93.24, after a previous close of $93.32. The stock reached a daily high of $93.25 and a low of $91.59, with a 52-week high of $93.67 and a 52-week low of $49.33.

Can Indians buy Globus Medical shares?

Yes, Indians can invest in the Globus Medical (GMED) from India.

With INDmoney, you can buy Globus Medical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Globus Medical at zero transaction cost.

How can I buy Globus Medical shares from India?

It is very easy to buy Globus Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Globus Medical be purchased?

Yes, you can buy fractional shares of Globus Medical with INDmoney app.

What are the documents required to start investing in Globus Medical stocks?

To start investing in Globus Medical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.